Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
23.03.2026 - 14:30:22 | dgap.de| Solvias / Key word(s): ESG/Miscellaneous 23.03.2026 / 14:30 CET/CEST The issuer is solely responsible for the content of this announcement. Recognition highlights progress in environmental, social, and governance (ESG) initiatives for the global CMC analytics provider. KAISERAUGST, Switzerland, March 23, 2026 /PRNewswire/ -- Solvias, a global provider of chemistry, manufacturing, and controls (CMC) analytics for the life sciences industry, today announced it has earned a Bronze Medal from EcoVadis, one of the world's most trusted providers of business sustainability ratings. The recognition places Solvias in the top 35% of more than 100,000 companies evaluated by EcoVadis worldwide. ![]() Establishing sustainability targets Implementing a five-year ESG roadmap Strengthening governance, ethical business practices, and sustainable procurement standards "Earning the EcoVadis Bronze Medal reflects the meaningful progress our teams have made in embedding sustainability into our operations and business practices," said Archie Cullen, CEO of Solvias. "This recognition underscores our commitment to continuous improvement as we support our partners in advancing life-changing therapies responsibly." Advancing Sustainable Practices in Life Sciences As a partner to pharmaceutical, biotech, and life sciences companies, Solvias continues to expand initiatives aimed at reducing environmental impact while strengthening responsible business practices. The company's long-term sustainability strategy includes further alignment with internationally recognized frameworks such as the Science Based Targets initiative (SBTi), along with ongoing improvements in ESG transparency. By embedding sustainability into its operational and strategic priorities, Solvias aims to support innovation in drug development while contributing to more sustainable healthcare and life sciences supply chains. About Solvias Solvias is a global provider of chemistry, manufacturing, and controls (CMC) analytics and regulatory services for the life sciences industry. Its expert teams support pharmaceutical and biotech companies across small molecules, biologics, and novel modalities, delivering analytical solutions from raw material testing to drug product release. Headquartered near Basel, Switzerland, Solvias operates five global Centers of Excellence, all adhering to the highest ISO, GMP, GLP, and FDA standards. Learn more at www.solvias.com Logo - https://mma.prnewswire.com/media/2321760/solvias_logo_2clr_Logo.jpg ![]() 23.03.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
So schätzen die Börsenprofis Aktien ein!
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
Für. Immer. Kostenlos.
en | boerse | 68967828 |


